VPR Brands, LP will be attending the Marcum MicroCap

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
140
VPR Brands, LP will be attending the Marcum MicroCap Conference in New York

FORT LAUDERDALE, FL--(Marketwired - Jun 14, 2017) - VPR Brands, LP ( OTC PINK : VPRB ), a market leader specializing in vaporizers and accessories for essential oils, cannabis concentrates, and extracts will have a presentation table at the Marcum MicroCap Conference taking place at the Grand Hyatt New York on June 15 th and 16 th .

"This conference attracts the who's who in the microcap space all coming together in a friendly and professional environment. In a short time the Marcum Conference has become one of the best attended investor conferences of its kind," said Kevin Frija, CEO of VPR Brands, LP. "We will be handing out company literature and showcasing our products on a table top display throughout the whole event on the conference level floor and look forward to networking and gaining awareness within the microcap investment community."

"As the cannabis investment opportunities mature and investors become more educated about the industry I believe it is important for us to attend these conferences, which will place our company and products in front of the microcap investment community. I believe having the presentation table will allow us to best network and create positive awareness of our company and brands," said Dan Hoff, COO of VPR Brands, LP.

About Marcum MicroCap Conference The Marcum MicroCap Conference is presented by Marcum LLP, a top national accounting and advisory firm and the #7 ranked SEC practice in the U.S. Since its launch in 2012, this event has become a nationally recognized forum for publicly traded companies with less than $500 million in market capitalization to network with fund managers and high net worth investors who focus on small cap equities. More than 2,000 participants from all segments of the microcap market attend the Marcum MicroCap Conference each year, including venture and lower middle-market private equity investors, institutional investors, investment bankers, and buy- and sell-side analysts.

About VPR Brands, LP: VPR Brands is a technology company, whose assets include issued U.S. and Chinese patents for atomization related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids. Vaporizers and electronic cigarettes (also known as e-cigarettes) are devices which deliver nicotine and or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products. For more information about VPR Brands, please visit the company on the web at www.vprbrands.com and www.vapehoneystick.com

Forward-looking statements: This news release contains statements that involve expectations, plans or intentions, and other factors discussed from time to time in the company's Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. The company cautions readers not to place undue reliance on any forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Contact Information: VPR Brands, LP Kevin Frija CEO (954) 715-7001 info@vprbrands.com www.vprbrands.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Brixton Metals Expands Thorn Project with New Mineral Claims

Updated Category News Views 198

Brixton Metals Expands Thorn Project with New Mineral Claims Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) has expanded its footprint at the Thorn Project, securing a 100% interest in mineral claims covering 6,446 hectares. These claims, which were previously outside Brixton’s control, sit northwest of the well-known Golden Bear Mine and add ground the company...

Continue Reading
Nutex Health Awaits Q2 Results Amid Regulatory Hurdles

Updated Category News Views 20

Diving headfirst into the grumbles of this healthcare whirlwind we call Nutex Health. They've set the table to drop their Q2 financials on August 6, right after the bell, followed by a chat with investors the next morning. We're talking bumper-to-bumper business news here, and everyone with a slice in NASDAQ: NUTX better have their ears pricked. Nutex Health: A Mixed Bag...

Continue Reading
Arvore Partners LP Announces Impressive October Distribution

Updated Category News Views 183

Arvore Partners LP Declares Monthly Distribution for October Arvore Partners LP is thrilled to share details about the declaration of its monthly distribution for October. This distribution amounts to $687,365, which translates to an impressive 9.06% annualized yield for its unitholders, marking a 7% increase from the previous month. This consistent growth highlights...

Continue Reading
Key Insights on Marathon Petroleum's Upcoming Earnings Call

Updated Category News Views 101

An Overview of Marathon Petroleum's Earnings Expectations Marathon Petroleum (NYSE: MPC) is gearing up for its quarterly earnings announcement. Investors should prepare for necessary insights leading up to the release of this important announcement. Analysts predict a solid earnings per share (EPS) of $3.23 for the upcoming quarter. While it’s crucial for the company to...

Continue Reading
Revolutionizing Male Infertility Research with PacBio's Revio

Updated Category News Views 80

Transforming Male Infertility Research with PacBio's Revio MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading name in sequencing solutions, is launching an exciting collaboration with the University Hospital of Münster. This partnership is set to leverage long-read whole genome sequencing to significantly advance research in male infertility and rare diseases....

Continue Reading